Articles tagged "Kidney transplantation"

2018 American Transplant Congress
Disparity in Access to Kidney Allograft Offers among HIV+ Transplant Candidates
J. Cohen,¹ J. Locke,² B. Shelton,² R. Reed,² P. MacLennan,² D. Sawinski.¹
¹Renal Division, University of Pennsylvania, Philadelphia, PA; ²Comprehensive Transplant Institute, University of Alabama at Birmingham, Birmingham, AL.
Background: Despite having a demonstrated survival benefit with kidney transplantation, patients with chronic viral infections, such as HCV or HIV, face many barriers to transplantation,…
2018 American Transplant Congress
Comparing Outcomes between Induction Immunosuppressive Therapies in Simultaneous Heart/Kidney Transplantation
I. Moinuddin, J. Yu, L. Kang, C. Bhati, D. Bandyopadhyay, A. King, D. Kumar, L. Kamal, D. Tang, I. Yakubu, G. Gupta.
Virginia Commonwealth University, Richmond.
Introduction: There is no published data on the risks and benefits of Induction immunosuppression in simultaneous heart/kidney transplant (SHKT) patients.Methods: We analyzed all SHKT performed…
2018 American Transplant Congress
Inflammation in Scarred Areas (I-IFTA) is a Reflection of Parenchymal Injury (Response to Wounding) Not T Cell-Mediated Rejection
P. Halloran, J. Chang, K. Famulski.
Medicine, University of Alberta, Edmonton, AB, Canada.
Inflammation in fibrotic renal parenchyma (i-IFTA) is associated with decreased graft survival but by Banff rules is not diagnostic for rejection. Some researchers believe that…
2018 American Transplant Congress
Quality of Social Support Network and Access to Transplant: What Matters?
A. Waterman,^1,2 J. Beaumont,² S. Kawakita,² M. Dunbar-Forest,¹ G. Danovitch,¹ I. Hong,¹ C. Anderson,¹ M. Everly,^1,2 J. Peipert.^1,2
¹Division of Nephrology, David Geffen School of Medicine at UCLA, Los Angeles, CA; ²Terasaki Research Institute, Los Angeles, CA.
Recovery after kidney transplant (KT) requires adequate social support. Caregivers are asked to attend transplant evaluation and complete a caregiver contract. Little is known about…
2018 American Transplant Congress
Burden of Infectious Complications after Upper Extremity Allotransplantation: A Matched Cohort Study
A. Conrad,^1,2,3 P. Petruzzo,^4,5 J. Kanitakis,⁶ A. Gazarian,⁷ L. Badet,^3,8 P. Vanhems,^3,9 O. Thaunat,^1,3,10 E. Morelon,^1,3,10 A. Sicard.^1,3
¹Department of Transplantation, Nephrology and Clinical Immunology, Hospices Civils de Lyon (HCL), Lyon, France; ²Department of Infectious Diseases and Tropical Medicine, HCL, Lyon, France; ³Claude Bernard Lyon 1 University, Lyon, France; ⁴Department of Transplantation, HCL, Lyon, France; ⁵Department of Surgery, University of Cagliari, Cagliari, Italy; ⁶Department of Dermatology, HCL, Lyon, France; ⁷Clinique du Parc, Lyon, France; ⁸Department of Urology and Transplantation, HCL, Lyon, France; ⁹Infection Control and Epidemiology Unit, HCL, Lyon, France; ¹⁰INSERM U1111, International Center for Infectiology Research, Lyon, France.
This study aimed to assess the infectious risk after upper extremity allotransplantation (UEA), a non-vital transplantation procedure requiring lifelong immunosuppression. A matched cohort study was…
2018 American Transplant Congress
Thrombotic Microangiopathy after Renal Transplantation: A Clinicopathological Study and Identification of Prognostic Factors
K. Dessaix,¹ C. Bontoux,² O. Aubert,¹ J. Zuber,¹ R. Sberro Soussan,¹ V. Frémeaux-Bacchi,³ M. Le Quintrec,⁴ C. Legendre,¹ M. Rabant.²
¹Renal Transplantation Department, Necker-Enfants Malades Hospital, Paris, France; ²Pathology Department, Necker-Enfants Malades Hospital, Paris, France; ³Immunology Laboratory, Georges Pompidou European Hospital, Paris, France; ⁴Nephrology Department, CHU Montpellier, Montpellier, France.
IntroductionThrombotic microangiopathy (TMA), whether de novo or recurrent, is a serious complication after renal transplantation, but prognostic factors and the role of complement inhibitors in…
2018 American Transplant Congress
Kidney Transplantation and Progression of Peripheral Arterial Disease in the Ipsilateral Lower Extremity
A. Rasmussen,¹ R. Moore,¹ T. Schuler,¹ G. Todd,¹ K. Wen.²
¹Division of Urology, Department of Surgery, University of Alberta, Edmonton, AB, Canada; ²Division of Nephrology and Transplant Immunology, Department of Medicine, University of Alberta, Edmonton, AB, Canada.
Objectives:We aimed to investigate whether receiving a kidney transplant allograft graft increases the risk of ipsilateral lower limb amputation in patients with pre-existing peripheral arterial…
2018 American Transplant Congress
Trends and Policy Influences on Multiple Listing Practices for Kidney Transplantation between 2000 and 2017
M. Decoteau,¹ D. Stewart,² A. Toll,² J. Case,¹ C. Marsh.¹
¹Organ Transplantation, Scripps Green Hospital, La Jolla, CA; ²United Network for Organ Sharing, Richmond, VA.
BACKGROUND: Organ allocation policies continually evolve to address long transplant wait times and a limited donor organ pool. Transplant candidates may list at multiple centers…
2018 American Transplant Congress
Prevalence and Impact of CYP3A5 Genomic Variances on Clinical Outcomes among African-American Kidney Transplant Recipients
A. Maldonado,¹ S. Hudson,² L. Rebellato,² T. Asempa.¹
¹Vidant Medical Center, Greenville, NC; ²East Carolina University, Greenville, NC.
Introduction: Kidney transplantation in African American (AA) recipients continues to demonstrate inferior outcomes when compared with other race/ethnicities. Contributing factors encompass differences in pharmacogenomics, and…
2018 American Transplant Congress
Validating Molecular Microscope Readings and Estimating Agreement with Histology
P. Halloran, J. Reeve, The INTERCOMEX Study Group.
ATAGC, Edmonton, Canada.
We previously described a microarray diagnostic system (MMDx) for rejection in 1208 kidney transplant biopsies (J. Reeve et al. JCI Insight 2 (12), 2017). The…